News
The Food and Drug Administration has authorized more medical devices that incorporate artificial intelligence. Keep track of ...
FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...
The rollout will allow FDA scientists and subject-matter experts to spend less time on ‘tedious, repetitive tasks,’ the ...
On May 8, 2025, the Food and Drug Administration (FDA) announced the completion of its generative artificial intelligence (AI) pilot program ...
If mishandled, this move could undermine public trust in the FDA and squander a once-in-a-generation opportunity to lead the ...
If the initiative proceeds as planned, it will mark a pivotal shift in the regulatory landscape, introducing both efficiencies and novel ...
Explore more
The FDA has started exploring how AI can be used to accelerate drug approvals in collaboration with OpenAI amid oversight ...
Commissioner Martin Makary also said the agency would roll out a generative AI system across its centers that will help FDA ...
WASHINGTON, D.C.—FDA Commissioner Martin Makary, M.D., offered more details into the agency’s recently announced plans to ...
The FDA has appointed its first chief artificial intelligence officer, with an eye on supporting the agency’s internal IT ...
The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...
The FDA and NIH recently announced plans to phase out animal testing requirements for some therapies. While organoid and AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results